Clinical Trial Update: A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for TQB2450 in Stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Stage III Non-small-cell Lung Cancer | Phase 3 | Status: UNKNOWN